NMD Pharma - PIR International
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma
NMD Pharma A/S | LinkedIn
NMD Pharma Information | NMD Pharma Profile
NMD Pharma
NMD Pharma A/S | LinkedIn
NMD Pharma ApS Annual Report for 1 January - 31 December 2017
NMD Pharma breder sig til nye områder før næste kapitalrejsning
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
NMD Pharma
NMD Pharma A/S | LinkedIn
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Argenx køber amerikansk guldkupon til middel, som NMD Pharma skal konkurrere mod
NMD Pharma company information, funding & investors | Dealroom.co
Thomas H. Pedersen - CEO at NMD Pharma | The Org
Novo Holdings · NMD Pharma
NMD Pharma
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD Pharma
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
